Status:

COMPLETED

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Immune Tolerance Network (ITN)

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

8-30 years

Phase:

PHASE2

Brief Summary

Anti-CD3 monoclonal antibody (a.k.a. hOKT3gamma1 \[Ala-Ala\],teplizumab, MGA031) is a humanized antibody that is commonly used to prevent organ rejection. The purpose of this study is determine whethe...

Detailed Description

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks insulin-producing beta cells in the pancreas. Without these cells, the body cannot maintain proper blood glucose ...

Eligibility Criteria

Inclusion

  • Diagnosis of type 1 diabetes (according to American Diabetes Association \[ADA\] criteria) within the 8 weeks prior to study entry
  • Weigh at least 25 kg (55 lbs)
  • Insulin autoantibodies assessed within 10 days of any insulin use OR anti-glutamic acid decarboxylase (GAD) autoantibodies OR anti-ICA512/IA-2 autoantibodies
  • Subjects or guardian(s) willing to provide informed consent

Exclusion

  • Prior participation in a clinical trial that could potentially affect diabetes condition or immunologic status
  • Participation in another investigational clinical trial within the 6 weeks prior to study entry
  • Pregnancy or breastfeeding

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2011

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT00129259

Start Date

September 1 2005

End Date

March 1 2011

Last Update

May 22 2017

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

The Diabetes Center at UCSF

San Francisco, California, United States, 94143

2

Barbara Davis Center for Childhood Diabetes

Denver, Colorado, United States, 80262

3

Yale University

New Haven, Connecticut, United States, 06520

4

Medical College of Georgia

Augusta, Georgia, United States, 30912

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes | DecenTrialz